The largest database of trusted experimental protocols

Immunofluorescence assay

Manufactured by EUROIMMUN
Sourced in United States, Germany, Italy

The Immunofluorescence assay is a laboratory technique used to detect and visualize specific target molecules, such as proteins or antibodies, within cells or tissues. It utilizes fluorescent-labeled antibodies to bind to the target analytes and allows for their detection and quantification under a fluorescence microscope.

Automatically generated - may contain errors

4 protocols using immunofluorescence assay

1

Multispecies ELISA and Western Blot Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
The multispecies double antigen ELISA (IDVet, Grabels, France) was applied according to the manufacturer’s instructions. An in-house ELISA based on recombinant N protein and a species-adapted protocol for the commercial human Vector-Best IgG ELISA (Vector-Best, Novosibirsk, Russia) and an immunofluorescence assay (Euroimmun, Luebeck, Germany) were used as described before [28 (link)].
Western blot analysis was conducted according to standard procedures. For the immune detection, sera were diluted 1/20 in 5% skim milk and incubated for 1 h. Membranes were washed with PBS-Tween20 and the conjugate (Peroxidase-conjugated AffiniPure Goat Anti-Bovine IgG or Peroxidase-conjugated AffiniPure Donkey Anti-Sheep IgG, Jackson ImmunoResearch, Cambridgeshire, UK) was diluted to 1/3000 in 5% skim milk and added to the membrane. After 1 h, membranes were washed again and the substrate (SuperSignal West Pico PLUS Chemiluminescent Substrate, Thermo Scientific, Braunschweig, Germany) was applied. Chemiluminescence was measured with ChemiDocTM Touch Imaging System (Bio-Rad Laboratories, Hercules, CA, USA) and blots were analyzed with Image Lab software (Bio-Rad Laboratories, Hercules, CA, USA).
+ Open protocol
+ Expand
2

Autoimmune Biomarkers in Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used immune dot blot to determine the presence of anti-NXP2 antibody in human serum (D-TEK, Belgium). Creatine kinase (CK) were tested by automated biochemical analyzer (Siemens, Germany). Ferritin was measured by quantitative chemiluminescence assay (Abbott Laboratories, US). Anti-nuclear antibodies (ANA) and anti-Ro-52 antibodies were measured by immunofluorescence assay (Euroimmun, US) and immunoblotting (Euroimmun, US) respectively. We assessed CD4/CD8 ratio by flow cytometry and immunofluorescence (Becton, Dickinson and Company, US).
+ Open protocol
+ Expand
3

CCHFV Serodiagnostic Assay Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
DUGV antisera were run in three different CCHFV ELISA systems. (1) The multispecies double antigen ELISA (IDVet, Grabels, France) was applied according to the manufacturers’ instructions. (2) An in-house ELISA based on recombinant N protein and (3) a species-adapted protocol for the commercial human Vector-Best IgG ELISA (Novosibirsk, Russia). Moreover, an immunofluorescence assay (Euroimmun, Luebeck, Germany) was used as described before [31 (link)]. Western blot analyses were conducted according to standard procedures.
+ Open protocol
+ Expand
4

Fetal Cord Blood RSV Serology

Check if the same lab product or an alternative is used in the 5 most similar protocols
After delivery, fetal cord blood was collected for RSV serology as described previously 24 . Briefly, the last 10–15 cm of the umbilical cord was disinfected with iodine prior to removing the clamp and 5 ml of blood was collected by gravity less than 10 min after the cord was sectioned with disinfected scissors. Serum was prepared by centrifugation at 2,650 g for 20 min, and aliquots were stored at −80°C until use. Anti-RSV IgA, IgM, and IgG antibodies were quantified using an immunofluorescence assay (Euroimmun, Padova, Italy) following the manufacturer’s instructions. Positivity for RSV antibodies was determined based on previously published criteria: <1/20 dilution was considered negative, ≥1/20 positive, and ≥1/140 strongly positive 25 (link). Cord blood serum samples with positive RSV IgM and/or IgA in addition to positive IgG were considered seropositive for this study. This definition of neonatal seropositivity is similar to those used for diagnosis of other congenial infections including rubella, toxoplasmosis and parvovirus 26 (link)–28 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!